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Abstract: Objective   To determine the effects of exercise on individual cardiometabolic
syndrome (CMS) risk factors in adults with chronic spinal cord injury (SCI).
Design   Systematic review.
Data sources   English language searches of PubMed, Web of Science, EMBASE, and
Scopus (01/01/1970 to 31/07/2019).
Eligibility criteria for selecting studies   (1) original articles with statistical analysis, (2)
participants were adults with a SCI sustained ≥ 1-year ago, (3) exercise intervention
duration ≥ 2 weeks, and (4) included any CMS risk factor as an outcome. The
methodological quality of articles was assessed using the Downs and Black score.
Results   Sixty-five studies were included for the final analysis, including nine studies
classified as high quality (≥66%), 35 studies classified as fair quality (50-66%), and 21
studies classified as low quality (<50%). Improvements in waist circumference (4/6
studies) and markers of hepatic insulin sensitivity (4/5 studies) were reported following
upper-body aerobic exercise training, but no improvements in fasting glucose (8/8
studies), lipid profile (6/8 studies), systolic (8/9 studies) or diastolic blood pressure (9/9
studies) were observed. Improvements in markers of peripheral insulin sensitivity (5/6
studies) were observed following functional electrical stimulation (FES)-cycling.
Improvements in lipid profile (4/5 studies) were observed following upper-body
resistance training (RT) (with or without aerobic exercise). No consistent improvements
in CMS risk factors were observed following assisted ambulation, FES-hybrid, FES-
rowing, and FES-RT. 
Conclusion   Upper-body aerobic exercise training (>75% maximum heart rate)
appears to improve waist circumference and hepatic insulin sensitivity, but appears
insufficient for improving fasting glucose, lipid profile, or resting blood pressure. The
addition of RT to upper-body aerobic exercise may elicit favourable changes in the lipid
profile. More high-quality studies are needed to confirm if FES-cycling is effective at
improving peripheral insulin sensitivity.















It gives us great pleasure to submit the following revised manuscript to Archives of 
Physical Medicine and Rehabilitation: 
 
Title:  The effect of exercise on cardiometabolic risk factors in adults with 
chronic spinal cord injury: A systematic review 
 
We would like to thank Reviewer 2 for their further helpful and insightful comments and 
hope that you will find our responses and associated amendments have improved the 








Professor James Bilzon 
Professor of Human and Applied Physiology 
Cover Letter
Dear Gerald Choon-Huat Koh (Section Editor, APMR) 
 
We would like to submit a revised version of the manuscript entitled: The effect of exercise 
on cardiometabolic risk factors in adults with chronic spinal cord injury: A systematic 
review (Ref. No: ARCHIVES-PMR-D-19-01224R1). Please see our responses below, in 
green font, to the reviewer’s comments, in black font. All changes made to the manuscript 
have been recorded using track changes.   
 
We would like to thank the reviewers for their further comments. 
 
Reviewers Comments and Author Responses 
Reviewer 1: 




The authors have tried to address the issues raised in this revision. However, the reason why 
hand searching was done on only two journals viz. Journal of SCM and the Archives of 
PM&R remains unclear, when there are other accepted "most common journals" around 
which may yield relevant articles such as the American Journal of PM&R, European Journal 
of P&RM, and Journal RM. 
 
Thank you for your further comment  on this issue. We will try to clarify our approach and 
reassure the reviewer. The initial electronic search, included ALL journals listed in the 
PubMed database. The second phase included a search of the reference lists of all identified 
articles and previous systematic reviews, to identify further articles from ALL journals. The 
third and final phase included a hand-search of the two specific journals which had returned 
the highest proportion of articles in the initial search. We believe this to be a very thorough 
approach and in keeping with best practice in Systematic Reviews. Of course, it is not 
possible to hand-search all journals and you will see from Line 162 that this process only 
revealed one additional study. I have changed the text to make this systematic approach more 
explicit, as follows (Lines 100-104): 
 
“The reference list of included items and previous systematic reviews were checked and 
further articles identified. The final step involved hand-searching the journals which had 
returned the highest proportion of articles in the initial search, to identify any additional 
studies (e.g. Journal of Spinal Cord Medicine (1982-2018) and Archives of Physical 
Medicine and Rehabilitation (1985-2018)).” 
 
The difference between hepatic insulin sensitivity (line 235) and peripheral insulin sensitivity 
(line 241) is still confusing, especially when related terms such as fasting insulin 
concentration, reduction in glucose and insulin, fasting glucose, fasting glycemic control keep 
appearing at various points (e.g. lines 236, 285, 334-8) - please clarify for the readers' benefit. 
 
Thank you. For the benefit of the reader, we have included a new paragraph to explain these 
global terms (Lines 158-164): 
Detailed Response to Reviewers
“The terms hepatic insulin sensitivity and peripheral insulin sensitivity are used throughout 
this systematic review. Hepatic insulin sensitivity refers to insulin sensitivity in the fasted 
state and is measured by variables such as fasting insulin and/or glucose concentration and 
integrated indices such as HOMA-IR. Peripheral insulin sensitivity refers to insulin-mediated 
skeletal muscle glucose disposal and is usually measured by looking at blood glucose and 
insulin in responses to an oral glucose challenge (e.g. oral glucose tolerance test) and 
categorized using indices such as ISI-matsuda.” 
 
We have also inserted ISI-matsuda in to the list of abbreviations. 
 
There is a small error in line 166: "reviewer's" should be "reviewers". 
 
This has been corrected to “reviewers”.  
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The effect of exercise on cardiometabolic risk factors in adults with chronic spinal cord 1 
injury: A systematic review 2 
 3 
ABSTRACT 4 
Objective To determine the effects of exercise on individual cardiometabolic syndrome (CMS) 5 
risk factors in adults with chronic spinal cord injury (SCI). 6 
Data sources English language searches of PubMed, Web of Science, EMBASE, and Scopus 7 
(01/01/1970 to 31/07/2019). 8 
Study Selection Articles were included if they met the following criteria: (1) original articles 9 
with statistical analysis, (2) participants were adults with a SCI sustained ≥ 1-year ago, (3) 10 
exercise intervention duration ≥ 2 weeks, and (4) included any CMS risk factor as an outcome.  11 
Data Extraction The methodological quality of articles was assessed using the Downs and 12 
Black score. 13 
Data Synthesis Sixty-five studies were included for the final analysis, including nine studies 14 
classified as high quality (≥66%), 35 studies classified as fair quality (50-66%), and 21 studies 15 
classified as low quality (<50%). Improvements in waist circumference (4/6 studies) and 16 
markers of hepatic insulin sensitivity (4/5 studies) were reported following upper-body aerobic 17 
exercise training, but no improvements in fasting glucose (8/8 studies), lipid profile (6/8 18 
studies), systolic (8/9 studies) or diastolic blood pressure (9/9 studies) were observed. 19 
Improvements in markers of peripheral insulin sensitivity (5/6 studies) were observed 20 
following functional electrical stimulation (FES)-cycling. Improvements in lipid profile (4/5 21 
studies) were observed following upper-body resistance training (RT) (with or without aerobic 22 
exercise). No consistent improvements in CMS risk factors were observed following assisted 23 
ambulation, FES-hybrid, FES-rowing, and FES-RT.  24 





Conclusions Upper-body aerobic exercise training (>75% maximum heart rate) appears to 25 
improve waist circumference and hepatic insulin sensitivity, but appears insufficient for 26 
improving fasting glucose, lipid profile, or resting blood pressure. The addition of RT to 27 
upper-body aerobic exercise may elicit favourable changes in the lipid profile. More high-28 
quality studies are needed to confirm if FES-cycling is effective at improving peripheral 29 
insulin sensitivity.  30 
 31 
Key Words spinal cord injuries, exercise therapy, metabolic diseases 32 
 33 
Abbreviations 34 
CMS cardiometabolic syndrome 35 
DBP diastolic blood pressure 36 
ES effect size 37 
FES functional electrical stimulation 38 
HDL-C high-density lipoprotein-cholesterol 39 
HOMA-IR homeostatic model assessment insulin resistance 40 
HRR heart rate reserve 41 
ISI-matsuda insulin sensitivity index 42 
LDL-C low-density lipoprotein-cholesterol  43 
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RCT randomised controlled trial  45 
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Persons with a spinal cord injury (SCI) are at an increased risk of cardiovascular disease and 50 
diabetes compared to able-bodied individuals [1, 2]. The risk of developing these chronic 51 
diseases is raised in individuals who present with a clustering of associated risk factors 52 
including: obesity, insulin resistance, dyslipidaemia, and hypertension, or as commonly 53 
referred to, cardiometabolic syndrome (CMS) [3]. The International Diabetes Federation 54 
defines CMS as central obesity (indicated by waist circumference), plus the presence (or 55 
treatment) of two of more of the following: hypertriglyceridemia (≥ 1.7 mmol/L), reduced high-56 
density lipoprotein-cholesterol (HDL-C) (< 1.03 mmol/L for men, < 1.29 mmol/L for women), 57 
hypertension (systolic blood pressure ≥ 130 mmHg, or diastolic blood pressure ≥ 85 mmHg), 58 
and raised fasting plasma glucose (≥ 5.6 mmol/L, or diagnosed with type 2 diabetes) [4]. A 59 
waist circumference greater than 94 cm and/or a body mass index of greater than 22 kg/m2 60 
have been suggested as suitable cut-points to define central obesity in SCI [5, 6]. The 61 
prevalence of CMS in chronic SCI appears to be high; with the largest study to date (n=473) 62 
reporting a prevalence rate of 57.5% [7].  63 
 There is strong evidence that exercise is an effective countermeasure for the prevention 64 
of chronic disease and the treatment of CMS risk factors in the able-bodied population [8]. This 65 
has allowed national and global health organisations to produce guidelines regarding the total 66 
volume and intensity of physical activity (minimum of 150 min/week of moderate-intensity, or 67 
75 minutes/week of vigorous-intensity) required to improve cardiometabolic health [9, 10]. 68 
However, as the most recent systematic review of the effect of exercise on health in SCI 69 
concluded, the evidence base for spinal cord injured persons “lags far behind” that for the 70 
general population [11]. This review formed the basis for the latest SCI-exercise guidelines, 71 
which recommend adults with a chronic SCI perform a minimum of 90 min/week of moderate-72 
to-vigorous intensity aerobic exercise to improve cardiometabolic health [12]. Additional 73 





factors, including systemic inflammation (C - reactive protein) and obesity (fat mass and waist 75 
circumference) in persons with chronic SCI [13, 14].  76 
 Since the last systematic search of the literature by van der Scheer and colleagues 77 
(search date: 1st Jan 2016), several randomised controlled trials assessing the effect of exercise 78 
training on CMS risk factors in SCI have been published. However, this systematic review did 79 
not address clinical thresholds for CMS risk factors at baseline, the magnitude of change 80 
following exercise training, and how different exercise modalities may impact specific 81 
individual CMS biomarkers. These questions are important for practitioners prescribing 82 
exercise to patients presenting with CMS risk factors, and researchers designing future studies 83 
in this field. A review which addresses these importance issues and focuses specifically on how 84 
different forms of exercise impacts on individual CMS risk factors in chronic SCI is therefore 85 
required. The aim of this systematic review is to determine the effect of different exercise 86 
modality interventions on CMS risk factors in adults with chronic SCI.  87 
 88 
METHODS  89 
 The study inclusion criteria and planned analysis were specified in advance 90 
(PROSPERO:CRD42018105110) and the Preferred Reporting Items for Systematic Review 91 
and Meta-Analyses (PRISMA) guidelines were followed [15]. The databases of PubMed, Web 92 
of Science, EMBASE, and Scopus (Elsevier) were searched on 22nd August 2018, using a 93 
search strategy formulated based on a similar previous systematic review [11]. The search was 94 
repeated on 31st July 2019 to identify any additional articles prior to publication. The search 95 
strategy was piloted to ensure known articles were included and reviewed by two authors (MF 96 
& TN). The full search strategy for PubMed is presented in Supplement 1 as an exemplar. 97 
Briefly, the search was performed by combining key words associated with SCI (e.g., 98 





“functional electrical stimulation”) and CMS risk factors (e.g., “glucose”, “BMI”, “blood 100 
pressure”). The reference list of included items and previous systematic reviews were checked 101 
and further articles identified. The final step involved hand-searching the journals which had 102 
returned the highest proportion of articles in the initial search, to identify any additional studies 103 
(e.g. Journal of Spinal Cord Medicine (1982-2018) and Archives of Physical Medicine and 104 
Rehabilitation (1985-2018)).  105 
Titles and abstracts of retrieved articles were independently screened for relevance by 106 
two reviewers (MF & TN). The same two reviewers independently assessed the full text of 107 
relevant articles for eligibility. In the event of any disagreements in article selection, a third 108 
reviewer (JB) made the final decision. Articles were included if they met the criteria according 109 
to the PICOS structure: i) participants - ≥50% of participants were aged ≥18 years old, and had 110 
a chronic SCI (≥1 year post-injury), ii) intervention - included an exercise training programme 111 
(any, or combination of: voluntary upper-body exercise, lower-body functional electrical 112 
stimulation (FES), and assisted ambulation training) lasting ≥2 weeks, iii) comparison – studies 113 
comparing exercise intervention to a control group or pre-intervention data, iv) outcomes - 114 
study included at least one CMS risk factor as an outcome variable (see Table 1) [4], and v) 115 
study design - study employed and reported quantitative statistical analysis to determine the 116 
impact of the exercise intervention on the relevant CMS risk outcome(s) (i.e. case reports and 117 
case-series were excluded), and was published in an English-language peer-reviewed journal 118 
(i.e. abstracts and conference proceedings were excluded) between 1st January 1970 and the 119 
final search date. Studies involving solely neuromuscular electrical stimulation (NMES) with 120 
no functional movement and passive cycling were excluded on the basis that the skeletal 121 
muscle contractions produced during these activities do not directly produce a functional 122 
movement, and therefore cannot be classed as exercise, per se. Studies assessing the impact of 123 





of the exercise intervention was to increase resting blood pressure, and therefore was not 125 
reflective of a CMS risk factor (i.e. hypertension). 126 
Two articles did not identify participants’ time since injury [16, 17]. The corresponding 127 
authors were contacted by email and asked to provide clarification and given two weeks to 128 
respond. Both articles were excluded as the corresponding authors were unable to provide this 129 
information.   130 
 Two reviewers (MF and JM) independently evaluated the quality of included studies 131 
using a modified Downs and Black scale [18]. In the modified version, the scoring for question 132 
27 (relating to statistical power) is simplified to “Yes” (1) or “No” (0). In the event of any 133 
discrepancies in scoring, discussion between the reviewers was used to reach a consensus. The 134 
total Downs & Black score for each article was expressed as a percentage of the maximum 135 
score possible (28) to allow categorisation of study quality [19]. Articles were classified as 136 
high (≥66.7%), fair (between 50.0% and 66.6%), or low (<50.0%) quality [19]. 137 
  An insufficient number of studies examined the same outcomes following similar 138 
exercise modalities, precluding a meta-analysis. Therefore, a coding system [19] was used to 139 
summarise the effect of different exercise training modalities on each CMS risk factor (Table 140 
2). If 0-33% of studies reported a statistically significant change in a specific CMS risk factor 141 
following exercise training, the result was categorised as ‘no effect’. If 34-59% of studies 142 
reported a statistically significant change in a CMS risk factor following exercise training, the 143 
result was categorised as ‘inconsistent’. If 60-100% of studies reported a statistically significant 144 
change in a CMS risk factor following exercise training, the result was categorised as 145 
‘positive’.  If four or more studies reported the same effect, the result was highlighted in bold 146 
to indicate a consistent finding.  The findings from one particular study [20] were counted as 147 





values not reported. Data extraction was performed by MF, and later checked independently 149 
by TN, JM, and JB. 150 
 To aid interpretation of results, group average values at baseline for body mass index 151 
(≥22 kg/m2) [6], waist circumference (>94 cm) [5], triglycerides (TG) (≥1.7 mmol/L), total 152 
cholesterol (TC) (≥5 mmol/L), low-density lipoprotein (LDL-C) (>3 mmol/L), HDL-C (<1.03 153 
mmol/L), fasting glucose (≥5.6 mmol/L), systolic blood pressure (SBP) (≥130 mmHg), and 154 
diastolic blood pressure (DBP) (≥85 mmHg) [4] were highlighted to indicate that they can be 155 
classified as clinically high, according to the International Diabetes Federation and SCI-156 
specific guidelines (Tables 3-9). 157 
The terms hepatic insulin sensitivity and peripheral insulin sensitivity are used 158 
throughout this systematic review. Hepatic insulin sensitivity refers to insulin sensitivity in the 159 
fasted state and is measured by variables such as fasting insulin and/or glucose concentration 160 
and integrated indices such as HOMA-IR. Peripheral insulin sensitivity refers to insulin-161 
mediated skeletal muscle glucose disposal and is usually measured by looking at blood glucose 162 
and insulin in responses to an oral glucose challenge (e.g. oral glucose tolerance test) and 163 
categorized using indices such as ISI-matsuda. 164 
 165 
RESULTS 166 
 The initial database search yielded a total of 2450 unique records, of which 2245 were 167 
excluded following title and abstract screening. An additional 10 articles were retrieved from; 168 
hand-searching of relevant journals (n=1), relevant systematic reviews (n=2), the associated 169 
reference list of an included paper (n=4), and the updated search (n=3). Therefore, the full-text 170 
of 215 studies were subsequently assessed, three papers [21-23] contained data presented in 171 
another article, and these were removed from all analysis, leaving 65 articles for final review. 172 





 There was substantial agreement between reviewers for title and abstract screening 174 
(k=0.635, 95% CI: 0.581, 0.689), and almost perfect agreement for the full-text screening 175 
(k=0.880, 95% CI: 0.811, 0.949) [24].  176 
 We identified studies as pre-post designs (n=47), RCTs (n=15), non-randomised 177 
controlled trials (n=2), and a retrospective cohort study (n=1). Numerous studies utilised arm-178 
cranking (n=9), wheelchair ergometry (n=3), wheelchair treadmill propulsion (n=2), or hand-179 
cycling (n=2). These 16 studies were grouped together for analysis as voluntary upper-body 180 
aerobic exercise (Table 3). Seven studies utilised upper-body resistance training (RT) (with or 181 
without upper-body aerobic exercise) (Table 4). The most common exercise modality was FES-182 
cycling (n=17) (Table 5). Six studies utilised FES-resistance training (FES-RT) exercise (in 183 
the form of non-isometric knee extensions), and three studies involved a combination of FES-184 
cycling and FES-RT (Table 6). Studies which involved hybrid functional electrical stimulation 185 
(FES)-cycling (n=4) or FES-rowing (n=4) were grouped together as they both involve lower-186 
body FES combined with voluntary upper-body aerobic exercise (Table 7). Several studies 187 
utilised solely body weight supported treadmill training (n=6), FES-walking, exoskeletal body 188 
weight supported treadmill training (n=1), or robotic body weight supported treadmill training 189 
(n=1). These 10 studies were grouped together for analysis (Table 8). Studies that involved a 190 
combination of upper-body aerobic, upper-body RT and neuromuscular stimulation (n=1), or 191 
a combination of lower-body FES-RT, and BWSTT (n=1), were not grouped for qualitative 192 
analysis (Table 9).  193 
 Intervention durations ranged from four to 52 weeks, with the most common length of 194 
12 weeks (n=14). Training frequency ranged from 1 to 7 sessions per week, with three times 195 
per week the most common frequency of exercise performed (n=35). No serious adverse events 196 





Sample sizes ranged from four to 48. Only seven studies reported a-priori sample size 198 
calculations, and four of these met their target sample size (Table 10). There was a total of 872 199 
participants (658 men, 110 women, 104 NR) (Table 10). There were nine studies classified as 200 
high quality, 35 studies classified as fair quality, and 21 studies classified as low quality. The 201 
most commonly assessed outcome measures for obesity, glycaemic control, dyslipidaemia, 202 
inflammation, vascular dysregulation, and thrombotic state were body mass (n=28), 203 
interleukin-6 (n=7), HDL-C (n=23), fasting glucose (n=18), PAI-1 (n=3), and systolic blood 204 
pressure (n=22), respectively. No studies reported outcome measures of hip circumference, 205 







There are consistent findings that voluntary upper-body aerobic exercise (>75% HRMAX) is 209 
effective in reducing waist circumference, and improving hepatic insulin sensitivity (i.e. fasting 210 
insulin concentration and HOMA-IR), however it does not appear to improve fasting glucose 211 
concentrations, lipid profile or resting blood pressure in persons with chronic SCI. The addition 212 
of upper-body RT appears to have an inconsistent effect on lipid profiles, but given the limited 213 
number of high-quality studies on combined exercise modalities, more research is needed in 214 
this area. FES-cycling may improve outcomes relating to peripheral insulin sensitivity (i.e. 215 
ability of the skeletal muscle to dispose of glucose), but more high-quality studies are required 216 
to strengthen the available evidence. There is insufficient evidence to conclude if FES-217 
resistance training, FES-hybrid, FES-rowing, or assisted ambulation training improves any of 218 
these CMS risk factors.  219 
Four [27, 25, 34, 33] of the six studies utilising upper-body aerobic exercise reported a 220 
reduction in supine waist circumference (-1.9 to -3.7 cm, ES: 0.26-2.67), indicating that this 221 
form of exercise is effective for reducing central obesity. A reduction in waist circumference 222 
(-2.5 cm) was achieved with as few as 64 min/week of exercise at 65-75% HRR [25], though 223 
this reduction did not translate to any change in android fat mass [25]. There was also no change 224 
in visceral adipose tissue [26] following 180 min/week at 60-65% VȮ2peak of upper-body 225 
aerobic exercise. Future studies should combine both surrogate and gold-standard measures 226 
(i.e. DEXA/CT derived) of central obesity/adiposity to further elucidate changes in body 227 
composition. Given the relatively small skeletal muscle mass involved in upper-body aerobic 228 
exercise, it is perhaps unsurprising that there were consistent findings that body mass and BMI 229 
were unchanged, as reported in a previous systematic review [14]. Whilst not part of the search 230 





during the exercise intervention [26]. In order to better understand the isolated impact of 232 
prescribed exercise interventions on energy balance and body composition, future studies 233 
should also attempt to estimate total energy intake and total energy expenditure. This would 234 
account for any compensatory changes in diet or exercise behaviours, providing a better 235 
understanding of the overall impact of exercise interventions on energy balance in SCI [90].  236 
Guidelines for measuring these variables in persons with chronic SCI have been published 237 
elsewhere [91].  238 
Four [25, 28, 26, 33] of the five studies that measured fasting insulin resistance by 239 
HOMA-IR and/or fasting insulin concentrations reported a reduction (22-40%, ES: 1.07-1.78) 240 
following upper-body aerobic exercise, suggesting that this form of exercise is effective at 241 
improving hepatic insulin sensitivity (i.e. ability of the liver to dispose of glucose). The single 242 
study [31] to find no statistically significant change in fasting insulin concentration following 243 
upper-body aerobic exercise, reported that all five participants had a lower insulin 244 
concentration (22-76%, ES: 0.41) post-training, indicating that the study simply lacked the 245 
statistical power to demonstrate an effect. Despite the improvement in hepatic insulin 246 
sensitivity [92] observed following upper-body aerobic exercise, the three studies [26, 28, 31] 247 
that measured outcomes relating to peripheral insulin sensitivity [93] found no changes 248 
following training. This is likely as a result of the limited skeletal muscle mass involved (i.e. 249 
limited sink for glucose disposal). Furthermore, the upper-body skeletal musculature is usually 250 
already well-conditioned from habitual wheelchair propulsion, meaning that moderate-251 
intensity upper-body exercise is likely an insufficient stimulus to substantially promote 252 
molecular adaptations (e.g. GLUT4 translocation, mitochondrial biogenesis) associated with 253 
improved peripheral insulin sensitivity [94]. A high quality study reported no improvement in 254 
glucose or insulin area under the curve despite 180 min/week of exercise at 60-65% VȮ2peak 255 





recommended guidelines of 90 min/week [12] may be insufficient to improve markers of 257 
peripheral insulin sensitivity.  258 
 There are also numerous studies indicating that upper-body aerobic exercise alone does 259 
not improve fasting glucose, resting blood pressure (SBP, DBP), or lipid profiles (TC, HDL-260 
C, LDL-C, and TG). All eight studies [25, 26, 28, 31-35] measuring fasting glucose reported 261 
no change following upper-body aerobic exercise. However, only one study [34] reported a 262 
clinically elevated group mean glucose concentration at baseline (≥5.6 mmol/L). Nine studies 263 
[29, 35, 38, 39, 25, 26, 34, 32, 31] measured changes in resting blood pressure following upper-264 
body aerobic exercise. The only study [34] where participants presented with clinically 265 
elevated systolic blood pressure (≥130 mmHg) at baseline reported a reduction (3 mmHg, ES: 266 
0.66) following 10 weeks of exercise training (4 sessions/week 50-70% HRR, 60 min). Thus, 267 
a basement effect may explain the lack of significant changes in fasting glucose and resting 268 
blood pressure in participants presenting with healthy values at baseline. Eight studies 269 
measured TG, TC, HDL-C, or LDL-C [25, 26, 28, 32-35, 20] following upper-body aerobic 270 
exercise, including four with clinically high mean concentrations at baseline. Only two studies 271 
reported a significant reduction in any variable. One study [34] reported a 25% reduction (ES: 272 
0.31) in TG in participants with a clinically elevated mean concentrations at baseline (≥1.7 273 
mmol/L). One study reported improvements in HDL-C, LDL-C, TC: HDL-C and TG following 274 
60 mins/week at 70-80% HRR, however the threshold for significance was set at p<0.10 [40]. 275 
It therefore appears that upper-body aerobic exercise may not be an adequate stimulus to 276 
improve blood lipid profile irrespective of baseline values. This is likely due to the low energy 277 
expenditure achieved through upper-body exercise, which appears to drive changes in the lipid 278 
profile [95].  279 
  Upper-body RT (with or without aerobic exercise) appears to reduce central 280 





1.0 to -2.6 cm) or waist to hip ratio (-0.02). These changes were accompanied by a decrease in 282 
whole-body fat mass and visceral adipose tissue following 120 min/week of training (3 x 10 of 283 
50-70% 1RM, 20 min at 3-6 RPE) [42]. Upper-body RT (with or without aerobic exercise) 284 
may elicit improvements in lipid profile, with four [43-45, 40] out of the five retrieved studies 285 
reporting a beneficial effect of at least one marker (TC, HDL-C, LDL-C, TC: HDL-C, and TG). 286 
However, more studies are needed to determine this, particularly given the high-quality study 287 
reporting no change in the lipid profile following 16-weeks of twice-weekly combined training 288 
[42]. 289 
 Five [50, 54, 58, 60, 62] of the six studies to measure outcomes relating to peripheral 290 
insulin sensitivity reported a significant improvement following FES-cycling. The largest of 291 
these studies (n=18) [54] reported a significant reduction in glucose and insulin at multiple 292 
time-points during a 2-h oral glucose tolerance test following 10 weeks of exercise (2-3 293 
sessions/week, 30 min). However, four of these studies were rated as low quality, and therefore 294 
more high-quality studies are needed to confirm if FES-cycling can improve peripheral insulin 295 
sensitivity, which upper-body exercise appears unable to achieve.  Surprisingly, we identified 296 
no RCT’s assessing the efficacy of FES-cycling compared to a true control group (i.e. passive 297 
cycling or stretching), which should addressed in future research. Four studies reported no 298 
change in body mass following FES-hybrid or FES-rowing training. There was a distinct lack 299 
of training studies with sufficient breadth of outcomes to make any other meaningful 300 
conclusions on the effect of FES-RT, FES-hybrid, FES-rowing and assisted ambulation on 301 
CMS risk factors. Nonetheless, given that hybrid training (2 sessions/week, 18-32 min, 65-75% 302 
HRR) [25] improved a multitude of CMS risk factors (waist circumference, android fat 303 
percentage, TG, DBP), and that different exercise modalities appear to offer specific benefits 304 





FES-cycling combined with upper-body aerobic and resistance exercise) interventions should 306 
be conducted in this area of promise. 307 
 This review has highlighted the lack of research assessing novel markers of CMS risk, 308 
including outcomes relating to inflammation, DEXA/CT derived measured of central adiposity, 309 
and endothelial function. It is clear that many studies in the area recruit a convenience sample 310 
of relatively active and lean individuals, who are not reflective of the wider, chronic SCI 311 
population (i.e. poor metabolic health), which should be considered when interpreting results. 312 
For example, individuals with SCI have a significantly lower HDL-C compared to able-bodied 313 
controls (1.06 vs 1.28 mmol/L) [96], however only five of the 23 studies to measure HDL-C 314 
had a clinically low mean concentration at baseline (<1.03 mmol/L). As is widely 315 
acknowledged, this review has also confirmed the existing evidence base of exercise and CMS 316 
risk in SCI lacks sufficiently powered (four in total identified), high-quality studies (eight in 317 
total identified). However, this review identified 16 additional studies, published since the 318 
previous systematic review by van der Scheer and colleagues [11] that were all categorised as 319 
fair or high quality, including eight RCT’s.  320 
 321 
Study Limitations 322 
  The main limitation of this systematic review is the use of summary coding to draw 323 
conclusions regarding the effect of each exercise modality on specific CMS risk factors. Due 324 
to the variability in CMS risk factors measured, exercise modes and training parameters (i.e. 325 
exercise intensity and volume), and participant characteristics (i.e. paraplegic vs. tetraplegic), 326 
a meta-analysis was not possible. Whilst the coding system provides a useful assessment of the 327 
consistency of findings in the field, it uses arbitrary classifications and does not distinguish 328 
studies of differing quality. However, when studies rated as ‘low-quality’ were removed from 329 





potential of FES-cycling to improve peripheral insulin sensitivity. Further, given that the vast 331 
majority of included studies lacked sufficient statistical power, there is a risk of a type II error 332 
in the conclusions formed. Finally, this review did not include acute SCI as van der Scheer and 333 
colleagues [11] determined there was an “absence of high-quality, consistent evidence” in this 334 






  337 
 In summary, this systematic review has provided evidence that in adults with chronic 338 
SCI, upper-body aerobic exercise improves outcomes relating to central obesity and hepatic 339 
insulin sensitivity, but is not sufficient to improve fasting glucose, lipid profiles, or resting 340 
blood pressure. Practitioners should consider prescribing moderate-to-vigorous intensity 341 
(>75% HRMAX) upper-body aerobic exercise to improve fasting glycaemic control and central 342 
obesity. To elicit improvements in lipid profile, this should be combined with upper-body 343 
resistance training. More high-quality randomised controlled trials assessing novel markers of 344 
CMS and responses to combined exercise interventions (e.g. aerobic exercise with resistance 345 
training), high-intensity exercise interventions, and FES-based exercise are needed to inform 346 
and refine evidence-based exercise guidelines for the prevention and management of CMS in 347 
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The effect of exercise on cardiometabolic risk factors in adults with chronic spinal cord 1 
injury: A systematic review 2 
 3 
ABSTRACT 4 
Objective To determine the effects of exercise on individual cardiometabolic syndrome (CMS) 5 
risk factors in adults with chronic spinal cord injury (SCI). 6 
Data sources English language searches of PubMed, Web of Science, EMBASE, and Scopus 7 
(01/01/1970 to 31/07/2019). 8 
Study Selection Articles were included if they met the following criteria: (1) original articles 9 
with statistical analysis, (2) participants were adults with a SCI sustained ≥ 1-year ago, (3) 10 
exercise intervention duration ≥ 2 weeks, and (4) included any CMS risk factor as an outcome.  11 
Data Extraction The methodological quality of articles was assessed using the Downs and 12 
Black score. 13 
Data Synthesis Sixty-five studies were included for the final analysis, including nine studies 14 
classified as high quality (≥66%), 35 studies classified as fair quality (50-66%), and 21 studies 15 
classified as low quality (<50%). Improvements in waist circumference (4/6 studies) and 16 
markers of hepatic insulin sensitivity (4/5 studies) were reported following upper-body aerobic 17 
exercise training, but no improvements in fasting glucose (8/8 studies), lipid profile (6/8 18 
studies), systolic (8/9 studies) or diastolic blood pressure (9/9 studies) were observed. 19 
Improvements in markers of peripheral insulin sensitivity (5/6 studies) were observed 20 
following functional electrical stimulation (FES)-cycling. Improvements in lipid profile (4/5 21 
studies) were observed following upper-body resistance training (RT) (with or without aerobic 22 
exercise). No consistent improvements in CMS risk factors were observed following assisted 23 
ambulation, FES-hybrid, FES-rowing, and FES-RT.  24 





Conclusions Upper-body aerobic exercise training (>75% maximum heart rate) appears to 25 
improve waist circumference and hepatic insulin sensitivity, but appears insufficient for 26 
improving fasting glucose, lipid profile, or resting blood pressure. The addition of RT to 27 
upper-body aerobic exercise may elicit favourable changes in the lipid profile. More high-28 
quality studies are needed to confirm if FES-cycling is effective at improving peripheral 29 
insulin sensitivity.  30 
 31 
Key Words spinal cord injuries, exercise therapy, metabolic diseases 32 
 33 
Abbreviations 34 
CMS cardiometabolic syndrome 35 
DBP diastolic blood pressure 36 
ES effect size 37 
FES functional electrical stimulation 38 
HDL-C high-density lipoprotein-cholesterol 39 
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HRR heart rate reserve 41 
ISI-matsuda insulin sensitivity index 42 
LDL-C low-density lipoprotein-cholesterol  43 
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RCT randomised controlled trial  45 
SBP systolic blood pressure 46 
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Persons with a spinal cord injury (SCI) are at an increased risk of cardiovascular disease and 50 
diabetes compared to able-bodied individuals [1, 2]. The risk of developing these chronic 51 
diseases is raised in individuals who present with a clustering of associated risk factors 52 
including: obesity, insulin resistance, dyslipidaemia, and hypertension, or as commonly 53 
referred to, cardiometabolic syndrome (CMS) [3]. The International Diabetes Federation 54 
defines CMS as central obesity (indicated by waist circumference), plus the presence (or 55 
treatment) of two of more of the following: hypertriglyceridemia (≥ 1.7 mmol/L), reduced high-56 
density lipoprotein-cholesterol (HDL-C) (< 1.03 mmol/L for men, < 1.29 mmol/L for women), 57 
hypertension (systolic blood pressure ≥ 130 mmHg, or diastolic blood pressure ≥ 85 mmHg), 58 
and raised fasting plasma glucose (≥ 5.6 mmol/L, or diagnosed with type 2 diabetes) [4]. A 59 
waist circumference greater than 94 cm and/or a body mass index of greater than 22 kg/m2 60 
have been suggested as suitable cut-points to define central obesity in SCI [5, 6]. The 61 
prevalence of CMS in chronic SCI appears to be high; with the largest study to date (n=473) 62 
reporting a prevalence rate of 57.5% [7].  63 
 There is strong evidence that exercise is an effective countermeasure for the prevention 64 
of chronic disease and the treatment of CMS risk factors in the able-bodied population [8]. This 65 
has allowed national and global health organisations to produce guidelines regarding the total 66 
volume and intensity of physical activity (minimum of 150 min/week of moderate-intensity, or 67 
75 minutes/week of vigorous-intensity) required to improve cardiometabolic health [9, 10]. 68 
However, as the most recent systematic review of the effect of exercise on health in SCI 69 
concluded, the evidence base for spinal cord injured persons “lags far behind” that for the 70 
general population [11]. This review formed the basis for the latest SCI-exercise guidelines, 71 
which recommend adults with a chronic SCI perform a minimum of 90 min/week of moderate-72 
to-vigorous intensity aerobic exercise to improve cardiometabolic health [12]. Additional 73 





factors, including systemic inflammation (C - reactive protein) and obesity (fat mass and waist 75 
circumference) in persons with chronic SCI [13, 14].  76 
 Since the last systematic search of the literature by van der Scheer and colleagues 77 
(search date: 1st Jan 2016), several randomised controlled trials assessing the effect of exercise 78 
training on CMS risk factors in SCI have been published. However, this systematic review did 79 
not address clinical thresholds for CMS risk factors at baseline, the magnitude of change 80 
following exercise training, and how different exercise modalities may impact specific 81 
individual CMS biomarkers. These questions are important for practitioners prescribing 82 
exercise to patients presenting with CMS risk factors, and researchers designing future studies 83 
in this field. A review which addresses these importance issues and focuses specifically on how 84 
different forms of exercise impacts on individual CMS risk factors in chronic SCI is therefore 85 
required. The aim of this systematic review is to determine the effect of different exercise 86 
modality interventions on CMS risk factors in adults with chronic SCI.  87 
 88 
METHODS  89 
 The study inclusion criteria and planned analysis were specified in advance 90 
(PROSPERO:CRD42018105110) and the Preferred Reporting Items for Systematic Review 91 
and Meta-Analyses (PRISMA) guidelines were followed [15]. The databases of PubMed, Web 92 
of Science, EMBASE, and Scopus (Elsevier) were searched on 22nd August 2018, using a 93 
search strategy formulated based on a similar previous systematic review [11]. The search was 94 
repeated on 31st July 2019 to identify any additional articles prior to publication. The search 95 
strategy was piloted to ensure known articles were included and reviewed by two authors (MF 96 
& TN). The full search strategy for PubMed is presented in Supplement 1 as an exemplar. 97 
Briefly, the search was performed by combining key words associated with SCI (e.g., 98 





“functional electrical stimulation”) and CMS risk factors (e.g., “glucose”, “BMI”, “blood 100 
pressure”). The reference list of included items and previous systematic reviews were checked 101 
and further articles identified. The final step involved hand-searching the journals which had 102 
returned the highest proportion of articles in the initial search, to identify any additional studies 103 
(e.g. Journal of Spinal Cord Medicine (1982-2018) and Archives of Physical Medicine and 104 
Rehabilitation (1985-2018)).  105 
Titles and abstracts of retrieved articles were independently screened for relevance by 106 
two reviewers (MF & TN). The same two reviewers independently assessed the full text of 107 
relevant articles for eligibility. In the event of any disagreements in article selection, a third 108 
reviewer (JB) made the final decision. Articles were included if they met the criteria according 109 
to the PICOS structure: i) participants - ≥50% of participants were aged ≥18 years old, and had 110 
a chronic SCI (≥1 year post-injury), ii) intervention - included an exercise training programme 111 
(any, or combination of: voluntary upper-body exercise, lower-body functional electrical 112 
stimulation (FES), and assisted ambulation training) lasting ≥2 weeks, iii) comparison – studies 113 
comparing exercise intervention to a control group or pre-intervention data, iv) outcomes - 114 
study included at least one CMS risk factor as an outcome variable (see Table 1) [4], and v) 115 
study design - study employed and reported quantitative statistical analysis to determine the 116 
impact of the exercise intervention on the relevant CMS risk outcome(s) (i.e. case reports and 117 
case-series were excluded), and was published in an English-language peer-reviewed journal 118 
(i.e. abstracts and conference proceedings were excluded) between 1st January 1970 and the 119 
final search date. Studies involving solely neuromuscular electrical stimulation (NMES) with 120 
no functional movement and passive cycling were excluded on the basis that the skeletal 121 
muscle contractions produced during these activities do not directly produce a functional 122 
movement, and therefore cannot be classed as exercise, per se. Studies assessing the impact of 123 





of the exercise intervention was to increase resting blood pressure, and therefore was not 125 
reflective of a CMS risk factor (i.e. hypertension). 126 
Two articles did not identify participants’ time since injury [16, 17]. The corresponding 127 
authors were contacted by email and asked to provide clarification and given two weeks to 128 
respond. Both articles were excluded as the corresponding authors were unable to provide this 129 
information.   130 
 Two reviewers (MF and JM) independently evaluated the quality of included studies 131 
using a modified Downs and Black scale [18]. In the modified version, the scoring for question 132 
27 (relating to statistical power) is simplified to “Yes” (1) or “No” (0). In the event of any 133 
discrepancies in scoring, discussion between the reviewers was used to reach a consensus. The 134 
total Downs & Black score for each article was expressed as a percentage of the maximum 135 
score possible (28) to allow categorisation of study quality [19]. Articles were classified as 136 
high (≥66.7%), fair (between 50.0% and 66.6%), or low (<50.0%) quality [19]. 137 
  An insufficient number of studies examined the same outcomes following similar 138 
exercise modalities, precluding a meta-analysis. Therefore, a coding system [19] was used to 139 
summarise the effect of different exercise training modalities on each CMS risk factor (Table 140 
2). If 0-33% of studies reported a statistically significant change in a specific CMS risk factor 141 
following exercise training, the result was categorised as ‘no effect’. If 34-59% of studies 142 
reported a statistically significant change in a CMS risk factor following exercise training, the 143 
result was categorised as ‘inconsistent’. If 60-100% of studies reported a statistically significant 144 
change in a CMS risk factor following exercise training, the result was categorised as 145 
‘positive’.  If four or more studies reported the same effect, the result was highlighted in bold 146 
to indicate a consistent finding.  The findings from one particular study [20] were counted as 147 





values not reported. Data extraction was performed by MF, and later checked independently 149 
by TN, JM, and JB. 150 
 To aid interpretation of results, group average values at baseline for body mass index 151 
(≥22 kg/m2) [6], waist circumference (>94 cm) [5], triglycerides (TG) (≥1.7 mmol/L), total 152 
cholesterol (TC) (≥5 mmol/L), low-density lipoprotein (LDL-C) (>3 mmol/L), HDL-C (<1.03 153 
mmol/L), fasting glucose (≥5.6 mmol/L), systolic blood pressure (SBP) (≥130 mmHg), and 154 
diastolic blood pressure (DBP) (≥85 mmHg) [4] were highlighted to indicate that they can be 155 
classified as clinically high, according to the International Diabetes Federation and SCI-156 
specific guidelines (Tables 3-9). 157 
The terms hepatic insulin sensitivity and peripheral insulin sensitivity are used 158 
throughout this systematic review. Hepatic insulin sensitivity refers to insulin sensitivity in the 159 
fasted state and is measured by variables such as fasting insulin and/or glucose concentration 160 
and integrated indices such as HOMA-IR. Peripheral insulin sensitivity refers to insulin-161 
mediated skeletal muscle glucose disposal and is usually measured by looking at blood glucose 162 
and insulin in responses to an oral glucose challenge (e.g. oral glucose tolerance test) and 163 
categorized using indices such as ISI-matsuda. 164 
 165 
RESULTS 166 
 The initial database search yielded a total of 2450 unique records, of which 2245 were 167 
excluded following title and abstract screening. An additional 10 articles were retrieved from; 168 
hand-searching of relevant journals (n=1), relevant systematic reviews (n=2), the associated 169 
reference list of an included paper (n=4), and the updated search (n=3). Therefore, the full-text 170 
of 215 studies were subsequently assessed, three papers [21-23] contained data presented in 171 
another article, and these were removed from all analysis, leaving 65 articles for final review. 172 





 There was substantial agreement between reviewers for title and abstract screening 174 
(k=0.635, 95% CI: 0.581, 0.689), and almost perfect agreement for the full-text screening 175 
(k=0.880, 95% CI: 0.811, 0.949) [24].  176 
 We identified studies as pre-post designs (n=47), RCTs (n=15), non-randomised 177 
controlled trials (n=2), and a retrospective cohort study (n=1). Numerous studies utilised arm-178 
cranking (n=9), wheelchair ergometry (n=3), wheelchair treadmill propulsion (n=2), or hand-179 
cycling (n=2). These 16 studies were grouped together for analysis as voluntary upper-body 180 
aerobic exercise (Table 3). Seven studies utilised upper-body resistance training (RT) (with or 181 
without upper-body aerobic exercise) (Table 4). The most common exercise modality was FES-182 
cycling (n=17) (Table 5). Six studies utilised FES-resistance training (FES-RT) exercise (in 183 
the form of non-isometric knee extensions), and three studies involved a combination of FES-184 
cycling and FES-RT (Table 6). Studies which involved hybrid functional electrical stimulation 185 
(FES)-cycling (n=4) or FES-rowing (n=4) were grouped together as they both involve lower-186 
body FES combined with voluntary upper-body aerobic exercise (Table 7). Several studies 187 
utilised solely body weight supported treadmill training (n=6), FES-walking, exoskeletal body 188 
weight supported treadmill training (n=1), or robotic body weight supported treadmill training 189 
(n=1). These 10 studies were grouped together for analysis (Table 8). Studies that involved a 190 
combination of upper-body aerobic, upper-body RT and neuromuscular stimulation (n=1), or 191 
a combination of lower-body FES-RT, and BWSTT (n=1), were not grouped for qualitative 192 
analysis (Table 9).  193 
 Intervention durations ranged from four to 52 weeks, with the most common length of 194 
12 weeks (n=14). Training frequency ranged from 1 to 7 sessions per week, with three times 195 
per week the most common frequency of exercise performed (n=35). No serious adverse events 196 





Sample sizes ranged from four to 48. Only seven studies reported a-priori sample size 198 
calculations, and four of these met their target sample size (Table 10). There was a total of 872 199 
participants (658 men, 110 women, 104 NR) (Table 10). There were nine studies classified as 200 
high quality, 35 studies classified as fair quality, and 21 studies classified as low quality. The 201 
most commonly assessed outcome measures for obesity, glycaemic control, dyslipidaemia, 202 
inflammation, vascular dysregulation, and thrombotic state were body mass (n=28), 203 
interleukin-6 (n=7), HDL-C (n=23), fasting glucose (n=18), PAI-1 (n=3), and systolic blood 204 
pressure (n=22), respectively. No studies reported outcome measures of hip circumference, 205 







There are consistent findings that voluntary upper-body aerobic exercise (>75% HRMAX) is 209 
effective in reducing waist circumference, and improving hepatic insulin sensitivity (i.e. fasting 210 
insulin concentration and HOMA-IR), however it does not appear to improve fasting glucose 211 
concentrations, lipid profile or resting blood pressure in persons with chronic SCI. The addition 212 
of upper-body RT appears to have an inconsistent effect on lipid profiles, but given the limited 213 
number of high-quality studies on combined exercise modalities, more research is needed in 214 
this area. FES-cycling may improve outcomes relating to peripheral insulin sensitivity (i.e. 215 
ability of the skeletal muscle to dispose of glucose), but more high-quality studies are required 216 
to strengthen the available evidence. There is insufficient evidence to conclude if FES-217 
resistance training, FES-hybrid, FES-rowing, or assisted ambulation training improves any of 218 
these CMS risk factors.  219 
Four [27, 25, 34, 33] of the six studies utilising upper-body aerobic exercise reported a 220 
reduction in supine waist circumference (-1.9 to -3.7 cm, ES: 0.26-2.67), indicating that this 221 
form of exercise is effective for reducing central obesity. A reduction in waist circumference 222 
(-2.5 cm) was achieved with as few as 64 min/week of exercise at 65-75% HRR [25], though 223 
this reduction did not translate to any change in android fat mass [25]. There was also no change 224 
in visceral adipose tissue [26] following 180 min/week at 60-65% VȮ2peak of upper-body 225 
aerobic exercise. Future studies should combine both surrogate and gold-standard measures 226 
(i.e. DEXA/CT derived) of central obesity/adiposity to further elucidate changes in body 227 
composition. Given the relatively small skeletal muscle mass involved in upper-body aerobic 228 
exercise, it is perhaps unsurprising that there were consistent findings that body mass and BMI 229 
were unchanged, as reported in a previous systematic review [14]. Whilst not part of the search 230 





during the exercise intervention [26]. In order to better understand the isolated impact of 232 
prescribed exercise interventions on energy balance and body composition, future studies 233 
should also attempt to estimate total energy intake and total energy expenditure. This would 234 
account for any compensatory changes in diet or exercise behaviours, providing a better 235 
understanding of the overall impact of exercise interventions on energy balance in SCI [90].  236 
Guidelines for measuring these variables in persons with chronic SCI have been published 237 
elsewhere [91].  238 
Four [25, 28, 26, 33] of the five studies that measured fasting insulin resistance by 239 
HOMA-IR and/or fasting insulin concentrations reported a reduction (22-40%, ES: 1.07-1.78) 240 
following upper-body aerobic exercise, suggesting that this form of exercise is effective at 241 
improving hepatic insulin sensitivity (i.e. ability of the liver to dispose of glucose). The single 242 
study [31] to find no statistically significant change in fasting insulin concentration following 243 
upper-body aerobic exercise, reported that all five participants had a lower insulin 244 
concentration (22-76%, ES: 0.41) post-training, indicating that the study simply lacked the 245 
statistical power to demonstrate an effect. Despite the improvement in hepatic insulin 246 
sensitivity [92] observed following upper-body aerobic exercise, the three studies [26, 28, 31] 247 
that measured outcomes relating to peripheral insulin sensitivity [93] found no changes 248 
following training. This is likely as a result of the limited skeletal muscle mass involved (i.e. 249 
limited sink for glucose disposal). Furthermore, the upper-body skeletal musculature is usually 250 
already well-conditioned from habitual wheelchair propulsion, meaning that moderate-251 
intensity upper-body exercise is likely an insufficient stimulus to substantially promote 252 
molecular adaptations (e.g. GLUT4 translocation, mitochondrial biogenesis) associated with 253 
improved peripheral insulin sensitivity [94]. A high quality study reported no improvement in 254 
glucose or insulin area under the curve despite 180 min/week of exercise at 60-65% VȮ2peak 255 





recommended guidelines of 90 min/week [12] may be insufficient to improve markers of 257 
peripheral insulin sensitivity.  258 
 There are also numerous studies indicating that upper-body aerobic exercise alone does 259 
not improve fasting glucose, resting blood pressure (SBP, DBP), or lipid profiles (TC, HDL-260 
C, LDL-C, and TG). All eight studies [25, 26, 28, 31-35] measuring fasting glucose reported 261 
no change following upper-body aerobic exercise. However, only one study [34] reported a 262 
clinically elevated group mean glucose concentration at baseline (≥5.6 mmol/L). Nine studies 263 
[29, 35, 38, 39, 25, 26, 34, 32, 31] measured changes in resting blood pressure following upper-264 
body aerobic exercise. The only study [34] where participants presented with clinically 265 
elevated systolic blood pressure (≥130 mmHg) at baseline reported a reduction (3 mmHg, ES: 266 
0.66) following 10 weeks of exercise training (4 sessions/week 50-70% HRR, 60 min). Thus, 267 
a basement effect may explain the lack of significant changes in fasting glucose and resting 268 
blood pressure in participants presenting with healthy values at baseline. Eight studies 269 
measured TG, TC, HDL-C, or LDL-C [25, 26, 28, 32-35, 20] following upper-body aerobic 270 
exercise, including four with clinically high mean concentrations at baseline. Only two studies 271 
reported a significant reduction in any variable. One study [34] reported a 25% reduction (ES: 272 
0.31) in TG in participants with a clinically elevated mean concentrations at baseline (≥1.7 273 
mmol/L). One study reported improvements in HDL-C, LDL-C, TC: HDL-C and TG following 274 
60 mins/week at 70-80% HRR, however the threshold for significance was set at p<0.10 [40]. 275 
It therefore appears that upper-body aerobic exercise may not be an adequate stimulus to 276 
improve blood lipid profile irrespective of baseline values. This is likely due to the low energy 277 
expenditure achieved through upper-body exercise, which appears to drive changes in the lipid 278 
profile [95].  279 
  Upper-body RT (with or without aerobic exercise) appears to reduce central 280 





1.0 to -2.6 cm) or waist to hip ratio (-0.02). These changes were accompanied by a decrease in 282 
whole-body fat mass and visceral adipose tissue following 120 min/week of training (3 x 10 of 283 
50-70% 1RM, 20 min at 3-6 RPE) [42]. Upper-body RT (with or without aerobic exercise) 284 
may elicit improvements in lipid profile, with four [43-45, 40] out of the five retrieved studies 285 
reporting a beneficial effect of at least one marker (TC, HDL-C, LDL-C, TC: HDL-C, and TG). 286 
However, more studies are needed to determine this, particularly given the high-quality study 287 
reporting no change in the lipid profile following 16-weeks of twice-weekly combined training 288 
[42]. 289 
 Five [50, 54, 58, 60, 62] of the six studies to measure outcomes relating to peripheral 290 
insulin sensitivity reported a significant improvement following FES-cycling. The largest of 291 
these studies (n=18) [54] reported a significant reduction in glucose and insulin at multiple 292 
time-points during a 2-h oral glucose tolerance test following 10 weeks of exercise (2-3 293 
sessions/week, 30 min). However, four of these studies were rated as low quality, and therefore 294 
more high-quality studies are needed to confirm if FES-cycling can improve peripheral insulin 295 
sensitivity, which upper-body exercise appears unable to achieve.  Surprisingly, we identified 296 
no RCT’s assessing the efficacy of FES-cycling compared to a true control group (i.e. passive 297 
cycling or stretching), which should addressed in future research. Four studies reported no 298 
change in body mass following FES-hybrid or FES-rowing training. There was a distinct lack 299 
of training studies with sufficient breadth of outcomes to make any other meaningful 300 
conclusions on the effect of FES-RT, FES-hybrid, FES-rowing and assisted ambulation on 301 
CMS risk factors. Nonetheless, given that hybrid training (2 sessions/week, 18-32 min, 65-75% 302 
HRR) [25] improved a multitude of CMS risk factors (waist circumference, android fat 303 
percentage, TG, DBP), and that different exercise modalities appear to offer specific benefits 304 





FES-cycling combined with upper-body aerobic and resistance exercise) interventions should 306 
be conducted in this area of promise. 307 
 This review has highlighted the lack of research assessing novel markers of CMS risk, 308 
including outcomes relating to inflammation, DEXA/CT derived measured of central adiposity, 309 
and endothelial function. It is clear that many studies in the area recruit a convenience sample 310 
of relatively active and lean individuals, who are not reflective of the wider, chronic SCI 311 
population (i.e. poor metabolic health), which should be considered when interpreting results. 312 
For example, individuals with SCI have a significantly lower HDL-C compared to able-bodied 313 
controls (1.06 vs 1.28 mmol/L) [96], however only five of the 23 studies to measure HDL-C 314 
had a clinically low mean concentration at baseline (<1.03 mmol/L). As is widely 315 
acknowledged, this review has also confirmed the existing evidence base of exercise and CMS 316 
risk in SCI lacks sufficiently powered (four in total identified), high-quality studies (eight in 317 
total identified). However, this review identified 16 additional studies, published since the 318 
previous systematic review by van der Scheer and colleagues [11] that were all categorised as 319 
fair or high quality, including eight RCT’s.  320 
 321 
Study Limitations 322 
  The main limitation of this systematic review is the use of summary coding to draw 323 
conclusions regarding the effect of each exercise modality on specific CMS risk factors. Due 324 
to the variability in CMS risk factors measured, exercise modes and training parameters (i.e. 325 
exercise intensity and volume), and participant characteristics (i.e. paraplegic vs. tetraplegic), 326 
a meta-analysis was not possible. Whilst the coding system provides a useful assessment of the 327 
consistency of findings in the field, it uses arbitrary classifications and does not distinguish 328 
studies of differing quality. However, when studies rated as ‘low-quality’ were removed from 329 





potential of FES-cycling to improve peripheral insulin sensitivity. Further, given that the vast 331 
majority of included studies lacked sufficient statistical power, there is a risk of a type II error 332 
in the conclusions formed. Finally, this review did not include acute SCI as van der Scheer and 333 
colleagues [11] determined there was an “absence of high-quality, consistent evidence” in this 334 






  337 
 In summary, this systematic review has provided evidence that in adults with chronic 338 
SCI, upper-body aerobic exercise improves outcomes relating to central obesity and hepatic 339 
insulin sensitivity, but is not sufficient to improve fasting glucose, lipid profiles, or resting 340 
blood pressure. Practitioners should consider prescribing moderate-to-vigorous intensity 341 
(>75% HRMAX) upper-body aerobic exercise to improve fasting glycaemic control and central 342 
obesity. To elicit improvements in lipid profile, this should be combined with upper-body 343 
resistance training. More high-quality randomised controlled trials assessing novel markers of 344 
CMS and responses to combined exercise interventions (e.g. aerobic exercise with resistance 345 
training), high-intensity exercise interventions, and FES-based exercise are needed to inform 346 
and refine evidence-based exercise guidelines for the prevention and management of CMS in 347 
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Table 1. CMS outcome measures 
Central 
Adiposity/Obesity 
Body Mass Index (BMI) 
Body Mass (BM) 
Waist Circumference (Waist) 
Hip Circumference 
Waist to Hip Ratio (WHR) 
Body Fat Percentage (BF%) (assessed via DEXA/CT) 
Fat Mass (FM) (assessed via DEXA/CT) 
Android Fat Mass 
Visceral Adipose Tissue (VAT) 
Liver Fat Content 
Leptin 
 
Glycaemic Control Fasting insulin and glucose 
Glucose to insulin ratio 
Fasting proinsulin 
Glycosylated haemoglobin (HbA1c) 
Fasting/postprandial insulin sensitivity measures 
C-peptide 
 
Dyslipidaemia Triglycerides (TG) 
Low-density lipoprotein-cholesterol (LDL-C) 
High-density lipoprotein-cholesterol (HDL-C) 
Total cholesterol (TC) 
DL, HDL, TC, TC: HDL-C 
 
Non-esterified fatty acids (NEFA) 
Free-fatty acids (FFA) 
Apolipoprotein B 
 
Inflammation C-reactive Protein (CRP) 
Interleukin-6 (IL-6) 
Tumour necrosis factor-alpha (TNF-α) 
Adiponectin 
 
Vascular Dysregulation Systolic Blood Pressure (SBP) 
Diastolic Blood Pressure (DBP) 
Pulse wave velocity (PWV) 
Flow-mediated dilation (FMD) 
Microalbuminuria  
 
Thrombotic State Fibrinogen 
Plasminogen activator inhibitor-1 (PAI-1) 
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Formatted: Pattern: Clear (Yellow)
Formatted: Pattern: Clear (Yellow)
Formatted: Pattern: Clear (Yellow)
Table 1
Table 2. Summary coding of studies examining the effect of exercise on CMS outcome measures. 








BM 1/9 (11%) 1/2 (50%) 1/3 (33%) 0/5 (0%) 1/4 (25%) 0/4 (0%) 
BMI 1/4 (25%) 1/4 (25%) 1/1 (100%) 0/1 (0%) 0/2 (0%) 1/3 (33%)* 
Waist 4/6 (66%) 2/3 (67%) - 1/2 (50%) - - 
WHR - 1/1 (100%) - - - - 
BF% 0/2 (0%) - 2/2 (100%) 0/2 (0%) 1/2 (50%) 0/2 (0%) 
FM 0/3 (0%) 1/2 (50%) 0/2 (0%) - 1/2 (50%) 0/2 (0%) 
Android FM 0/1 (0%) - - 0/1 (0%) - - 
Abdominal AT - - - -- 0/1 (0%) - 
VAT 0/1 (0%) 1/1 (100%) - -- - 0/2 (0%) 
Leptin 1/1 (100%) 0/1 (0%) - 1/1 (100%) - - 
 
Inflammation 
CRP 0/1 (0%) -- 1/1 (100%) 0/1 (0%) 1/2 (50%) 0/1 (0%) 
IL-6 1/2 (50%) 0/1 (0%) - 0/1 (0%) 1/2 (50%) 0/1 (0%) 
TNF-α 1/1 (100%) 0/1 (0%) - - 1/2 (50%) 0/1 (0%) 





TG 1/6 (17%) 2/4 (50%) 0/2 (0%) 1/1 (100%) 1/3 (33%) 1/3 (33%) 
FFA - - - - 0/1 (0%) 0/1 (0%) 
NEFA 0/1 (0%) - - - - - 
TC 1/6 (17%) 2/5 (40%) 1/2 (50%) 0/1 (0%) 0/2 (0%) 1/3 (33%) 
HDL-C 0/7 (0%) 1/5 (20%) 0/2 (0%) 0/2 (0%) 1/3 (33%) 1/3 (33%) 
LDL-C 0/5 (0%) 2/5 (40%) 1/2 (50%) 0/1 (0%) 1/3 (33%) 0/3 (0%) 







Fasting Glucose 0/8 (0%) 0/3 (0%) 0/1 (0%) 1/2 (50%) 0/1 (0%) 0/2 (0%) 
Fasting Insulin 4/5 (80%) 1/3 (33%) - 0/2 (0%) 0/3 (0%) 0/1 (0%) 
HbA1c 0/1 (0%) 0/1 (0%) - - - - 
HOMA-IR 4/4 (100%) 2/2 (100%) - 0/2 (0%) - 0/2 (0%) 
HOMA-%S 1/1 (100%) - - - - 0/1 (0%) 
HOMA-%β 0/2 (0%) - - - - 0/1 (0%) 
ISI-Matsuda 0/2 (0%) - - - - - 
Glucose OGTT 0/2 (0%) - 1/1 (100%) 0/1 (0%) 2/3 (66%) 0/3 (0%) 
Insulin OGTT 0/2 (0%) - 1/1 (100%) - 1/3 (33%) 0/2 (0%) 
IVGTT Si 0/1 (0%) - - - 0/2 (0%) 0/1 (0%) 
Cederholm Index - - - - 1/1 (100%) - 
HEC Si - - - - 1/1 (100%) - 
HEC Glucose - - - - 1/1 (100%) - 
Table 2
Thrombotic State PAI-1 1/2 (50%) 0/1 (0%) - - - - 





SBP 1/9 (11%) 0/3 (0%) 0/3 (0%) 0/2 (0%) 1/4 (25%) 0/1 (0%) 
DBP 0/9 (0%) 0/3 (0%) 0/3 (0%) 1/2 (50%) 1/3 (33%) 0/1 (0%) 
FMD - 0/1 (0%) - 1/2 (50%) - 1/1 (100%) 
PWV - 0/1 (0%) - - 0/1 (0%) - 
Albumin - - - - - 0/1 (0%) 
Black fill, white text: 0-33% of studies reported significant differences; grey fill, black text: 34-59% of studies reported significance differences; grey fill, white text: 60-100% of studies 
demonstrated positive significance differences, bold writing: ≥4 studies demonstrate the same effect. *one study reported a significant increase in BMI. NA; not applicable 
 
HOMA-IR; homeostatic model assessment insulin resistance, HOMA-%S; insulin sensitivity; HOMA-%β; beta cell function, ISI-Matsuda; insulin sensitivity index-Matsuda. OGTT; oral 
glucose tolerance test, IVGTT Si; intravenous glucose tolerance test insulin sensitivity, HEC Si; hypereuglycaemic clamp insulin sensitivity. 






n Intervention CMS Outcome Group Baseline  
Intervention (Control) 












65-75% HRR  
18-32 mins 
Waist (cm) 
Android Fat Mass (kg) 
Android Fat (%) 
TG (mmol/L) 
HDL-C (mmol/L) 
Fasting Glucose (mmol/L) 






89.7 ± 3.5 
2.6 ± 0.4  
38.6 ± 3.7 
1.2 ± 0.2  
1.4 ± 0.2  
5.3 ± 0.2  
54.6 ± 8.5 
1.9 ± 0.3 
119 ± 4  
72 ± 3  
2.86 ± 1.36  














































Body Mass (kg) 







Fasting Glucose (mmol/L) 




Glucose OGTT (%) 
Insulin OGTT (%) 
SBP (mmHg) 
DBP (mmHg) 
76.8 ± 13.3 (76.8 ± 11.3) 
27.6 ± 10.0 (25.5 ± 6.6) 
181 ± 85 (186 ± 47)  
1.2 ± 0.5 (1.3 ± 0.5)  
4.9 ± 1.0 (5.1 ± 0.9)  
1.1 ± 0.3 (1.0 ± 0.2)  
3.2 ± 0.9 (3.5 ± 0.8)  
0.6 ± 0.3 (0.7 ± 0.6) 
5.3 ± 0.5 (5.7 ± 1.3)  
54.8 ± 30.1 (41.3 ± 18.1)  
1.03 ± 0.57 (0.80 ± 0.35)  
87 ± 31 (66 ± 23)  
4.8 ± 2.2 (6.4 ± 3.1) 
- 
- 
128 ± 23 (128 ± 15)  
77 ± 15 (81 ± 13)  
-1.1 (-0.7)  
-0.6 (0.0)  
-22 (-3)  
-0.1 (+0.5)  
-0.1 (+0.1)  
+0.1 (0.0)  
0.0 (-0.2) 
+0.3 (-0.1) 
0.0 (0.0)  




+8 (-9)  
-8 (+6) 
-3 (-2)  



















































27.6 ± 4.1 (27.8 ± 4.4)  
98.1 ± 6.6 (98.4 ± 6.7)  
9.6 ± 2.7 (9.8 ± 2.8)  
29.8 ± 6.2 (30.2 ± 6.1)  
6.7 ± 2.2 (6.9 ± 2.3)  
23.3 ± 5.6 (23.6 ± 5.5)  
18.8 ± 4.1 (18.5 ± 4.2)  
-0.2 (NR)  
-3.7 (NR)  
-2.1 (+0.1)  
-0.7 (-0.1)  
-2.6 (+0.1)  
-2.7 (-0.1)  





























Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
Glucose: Insulin 
Glucose OGTT (AUC) 





34.9 ± 34.9 
25.1 ± 11.9 
4.50 ± 0.58  
0.94 ± 0.16  
2.71 ± 0.39  
5.54 ± 0.82  
84.9 ± 38.8  
9.77 ± 4.49 
- 
- 
1.6 ± 0.7 
111.4 ± 48.7 
73.3 ± 31.6 

























































65.6 ± 6.6  
23.5 ± 3.4  
110 ± 25 



































Body Mass (kg) 
BMI (kg/m2) 
BF (%) 
Fat Mass (kg) 
Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
IVGTT Insulin Sensitivity 
IVGTT Glucose Effectiveness 
SBP (mmHg) 
DBP (mmHg) 
80 ± 12 
28 ± 4 
40 ± 3.7 
31 ± 7 
5.27 ± 0.50 
76.4 ± 62.5 
- 
- 
119 ± 13 













































Fasting Glucose (mmol/L) 
SBP (mmHg) 
DBP (mmHg) 
86.5 (94.5)  
1.50 (1.38)  
4.57 (4.60)  
0.96 (1.05)  
2.87 (2.91)  
4.44 (4.47)  
100 (100)  
60 (60)  
+4.75 (+1.5) 
+0.06 (+0.29)  
+0.26 (+0.05)  
0.0 (+0.14)  
0.0 (0.09)  
-0.19 (+0.14)  
0 (0) 
































Fasting Glucose (mmol/L)  
Fasting Insulin (pmol/L) 
HOMA-IR 
22.0 ± 3.7 (20.8 ± 2.7) 
88.3 ± 13.1 (81.7 ± 9.0) 
1.16 ± 0.47 (1.09 ± 0.56) 
4.56 ± 0.92 (4.73 ± 0.55) 
1.10 ± 0.30 (1.17 ± 0.18) 
2.93 ± 0.67 (3.07 ± 0.62) 
4.36 ± 0.46 (4.92 ± 0.60) 
37.5 ± 16.7 (34.0 ± 20.1) 

















































61.0 ± 7.0 
85.5 ± 6.2 
1.74 ± 0.78 
5.25 ± 0.88 
1.45 ± 0.18 
2.95 ± 0.62 
5.66 ± 1.39 
4.9 ± 0.6 
5.2 ± 1.1 
2.97 ± 5.7 
136 ± 5 



















































Fasting Glucose (mmol/L) 
SBP (mmHg) 
DBP (mmHg) 
74 ± 10 
1.32 ± 0.59 
4.78 ± 1.09 
1.24 ± 0.26 
4 ± 1 
4.77 ± 1.94 
124 ± 10 











































Body Mass (kg) 
Waist (cm) 
82.1 ± 14.6 


















126 ± 12 















122 ± 5 (114 ± 6) 







Red font clinically high group average, bold font significant difference following intervention reported, ES effect size. 
ACE arm-crank ergometry, WCE wheelchair ergometer, WCT wheelchair treadmill ergometry, HRR heart rate reserve, 
V̇O2PEAK peak oxygen uptake, WPEAK peak power output, HRPEAK peak heart rate, HRMAX age-predicted maximum heart rate, 
BF body fat, HOMA-IR homeostatic model assessment of insulin resistance, OGTT oral glucose tolerance test, AUC area 
under the curve, IVGTT intravenous glucose tolerance test, NS non-significant, NR not reported  
*Group x time interaction for RCT and non-randomised controlled trial, or pre-post change for pre-post study designs.  







50 or 70% 
V̇O2PEAK 
















1.08 ± 0.32 (0.88 ± 0.26) 
5.04 ± 0.91 (4.81 ± 0.70) 
1.01 ± 0.28 (1.27 ± 0.28) 
3.54 ± 0.67 (3.15 ± 0.44) 





















Table 4. Detailed findings from upper-body RT (with or without aerobic training) studies 





n Intervention CMS Outcome Group Baseline  
Intervention (Control) 












17 16 weeks 
3 sessions/week 
RT: 20-25 mins, 2-




mins, 3-5 RPE 





23 16 weeks 
2 sessions/week 
RT: 3 x 10, 50-70% 
1RM 
Aerobic: >20 mins, 
3-6 RPE 
Body Mass (kg) 
BMI (kg/m2) 
Waist (cm) 



















83.4 ± 18.9 (78.6 ± 15.7) 
27.3 ± 5.2 (25.7 ± 4.9) 
96.2 ± 14.9 (89.6 ± 11.7) 
- (-) 
- (-) 
10.12 ± 13.25 (10.2 ± 12.8) 
1.3 ± 0.6 (1.1 ± 0.7) 
4.5 ± 0.9 (4.1 ± 0.9) 
1.01 ± 0.2 (1.13 ± 0.2) 
2.9 ± 0.9 (2.5 ± 0.7) 
4.6 ± 0.9 (3.8 ± 1.1) 
39.2 ± 29.5 (68.2 ± 77.9) 
1.01 ± 0.2 (1.13 ± 0.3) 
30.4 ± 17.7 (31.1 ± 22.7) 
116 ± 18 (118 ± 18) 




2.5 ± 2.2 (3.7 ± 2.1) 
4.7 ± 1.8 (4.1 ± 2.2) 







































































20 8 weeks 
3 sessions/week 
RT: 60-80% 1RM, 
5 exercises. 
BMI (kg/m2) 





Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
HOMA-IR 
25.3 ± 1.4 (24.9 ± 1.0) 
0.83 ± 0.02 (0.83 ± 0.14) 
1.77 ± 0.07 (1.80 ± 0.11) 
4.66 ± 0.18 (4.78 ± 0.10) 
1.12 ± 0.06 (1.15 ± 0.11) 
2.81 ± 0.10 (2.82 ± 0.12) 
5.46 ± 1.34 (5.45 ± 1.42) 
110.6 ± 19.5 (116.7 ± 24.9) 
































17 6 weeks 
3 sessions/week 
RT: 1-3 x 10-20 
Aerobic: 10-20 
mins, 4-8 RPE or 
65-85% HRMAX 





Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
HOMA-IR 
21.8 ± 2.9 (20.8 ± 1.9) 
84.1 ± 11.9 (79.4 ± 6.6) 
4.20 ± 0.88 (1.96 ± 0.09) 
1.26 ± 0.55 (1.32 ± 0.27) 
2.42 ± 0.81 (3.25 ± 0.76) 
4.50 ± 0.30 (4.20 ± 0.20)  
52.1 ± 32.6 (20.1 ± 7.6) 





























16 12 weeks 
3 sessions/week 











Fasting Glucose (mmol/L) 
SBP (mmHg) 
DBP (mmHg) 
74.9 ± 7.2 
26.0 ± 2.6 
104.1 ± 7.9 
1.41 ± 0.93 
5.66 ± 1.32 
1.26 ± 0.40 
4.20 ± 1.15 
5.81 ± 0.05 
118 ± 20 





































125 ± 23 (133 ± 20) 








1RM one-rep maximum, RPE rating of perceived exertion. *Group x time interaction for RCT and non-randomised controlled 
trial, or pre-post change for pre-post study designs. †True study design is RCT, presented as pre-post due to two different 




RT: 70-80% 1RM,  
Aerobic: 15-30 
mins, 70% HRMAX 


















2.29 ± 1.35 
4.73 ± 0.67 
1.05 ± 0.14 
3.06 ± 0.57 





















n Intervention CMS Outcome Group Baseline  
Intervention (Control) 



























0.37 ± 0.19 
1.99 ± 0.46 
0.48 ± 0.13 
1.13 ± 0.33 
12.59 ± 14.06 
6.29 ± 4.65 

































































Body Mass (kg) 
BMI (kg/m2) 
BF (%) 
Fat Mass (kg) 
Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
IVGTT Insulin Sensitivity (%) 
IVGTT Glucose Effectiveness (%) 
SBP (mmHg) 
DBP (mmHg) 
79 ± 12 
26 ± 5 
38 ± 5.7 
29 ± 8.6 
5.00 ± 0.11 
97.2 ± 118.1 
- 
- 
123 ± 8  






































Max load to finish 30 
min 
30 min 
2-h Glucose OGTT (mmol/L) 
2-h Insulin OGTT (pmol/L) 
7.77 ± 0.89 














Max load to finish 30 
min 
30 min 












Body Mass (kg) 
BMI (kg/m2) 
 
73.8 ± 13.9 










































Max load to finish 30 
min or fatigue 
Body Mass (kg) 





2-h Glucose OGTT 




69.6 ± 4.2 
22.9 ± 2.3  
1.18 ± 0.30 
4.08 ± 0.16 
0.88 ± 0.05 
2.65 ± 0.16 
- 
- 
15.92 ± 1.57 
4.91 ± 1.10 













































112 ± 6 








 *Group x time interaction for RCT and non-randomised controlled trial, or pre-post change for pre-post study designs. 













Fasting Insulin  



























Max load to finish 30 
min 
30 mins 
HEC Glucose Uptake (%) 
 








Max load to finish 30 
min 
30 mins 















Fasting Insulin (pmol/L) 
Glucose OGTT (AUC)  
Insulin OGTT (AUC) 
HEC SSGIR Step 1 (%) 
HEC SSGIR Step 2 (%) 
0.68 ± 0.08 
































Max load to finish 30 
min 
30 mins 
Body Mass  




















Cederholm Index - ↑ <0.05 - 
Table 6.  Detailed findings of FES-RT and combined (FES-cycling and FES-RT) studies 





n Intervention CMS Outcome Group Baseline  
Intervention (Control) 

















4 x 10  
~1 kg increments 
every 2 sessions 
Body Mass (kg) 
BMI (kg/m2) 
BF (%) 







IVGTT Insulin Sensitivity (%) 





80.5 ± 16 (77.5 ± 9.0) 
25 ± 4.5 (24.4 ± 3.6) 
32 ± 11 (33.4 ± 9) 
26.7 ± 12.5 (26.1 ± 8.0) 









5.5 ± 5.6 (5.9 ± 6.0) 
NR 





















































9 FES knee-extensions 
12 weeks 
2 sessions/week 
4 x 10 
Increased by ~1kg 
every 2 sessions 
Body Mass (kg) 
BMI (kg/m2) 
BF (%) 
Fat Mass (kg) 








Glucose OGTT (AUC) (%) 
Insulin OGTT (AUC) (%) 
74 ± 14 (76 ± 8) 
21 ± 5 (23 ± 3) 
30 ± 8 (29 ± 3) 
23.3 ± 9 (22 ± 2) 
103 ± 80 (106 ± 32) 
1.58 ± 1.38 (1.25 ± 0.28) 
0.58 ± 0.1 (0.53 ± 0.1) 
4.19 ± 1.27 (3.93 ± 0.70) 
0.78 ± 0.08 (0.83 ± 0.16) 
2.72 ± 0.93 (2.53 ± 0.67) 
5.6 ± 2 (5 ± 1) 

















































12 FES knee-extensions 
12 weeks 
3 sessions/week 
2 x 30 (25% Max), 1 x 
60 (12.5% Max) 
Increased by 0.5 kg 
per session  





14 FES knee-extensions 
16 weeks  
2 sessions/week 
4 x 10 
Increased by 0.9 kg 








Fasting Glucose (mmol/L) 




26.7 ± 4.7  
1.55 ± 0.94 
4.76 ± 1.03 
1.09 ± 0.40 
2.95 ± 0.94 
4.8 ± 1.8 
4.94 ± 1.05 
6.62 ± 4.30 
1.6 ± 1.4 
136.0 ± 112.0 






































5 FES knee extensions 
18 weeks 
2 sessions/week  
4 x 10 
Increased by 0.9-1.8 
kg every 2 sessions 
 
Posterior Tibial FMD (when 
adjusted for resting diameter) 









Albumin NR ↔ NS - 
Table 6
 
Max load to fatigue or 
45 reps (FES knee-
extensions) 








Max load to fatigue or 





114 ± 4 











5 FES knee-extensions 
12 weeks  
2 sessions/week 
4 x 10 
Increased by 0.9-1.8 
kg every 2 sessions 
Fasting Glucose (mmol/L) 
Fasting Insulin (mmol/L) 
2-h Glucose OGTT (mmol/L) 
2-h Insulin OGTT 
 
4.87 ± 0.58 
NR 






















15 mins each 
Body Mass (kg) 67.9 ± 5.2 +4.9 NS 0.65 
Table 7.  Hybrid and FES-rowing studies included in this review. 
HRPEAK peak heart rate, HRMAX age-predicted maximum heart rate, HOMA-IR homeostatic model assessment of insulin 
resistance, OGTT oral glucose tolerance test, NS non-significant, NR not reported   






n Intervention CMS Outcome Group Baseline  
Intervention (Control) 















Android Fat Mass (kg) 
Android Fat (%) 
TG (mmol/L) 
HDL-C (mmol/L) 
Fasting Glucose (mmol/L) 






91.8 ± 4.7 
2.0 ± 0.4 
33.4 ± 2.9 
1.7 ± 0.2 
1.1 ± 0.1 
5.7 ± 0.3 
72.7 ± 10.6 
2.8 ± 0.5 
112 ± 6 
69 ± 3 
3.91 ± 1.75 

















































Body Mass (kg) 
Relative Brachial FMD (%) 
Relative Femoral FMD (%) 























23.4 ± 3.7 












26 weeks  















Body Mass (kg) 
SBP (mmHg) 
DBP (mmHg) 
Absolute Brachial FMD (mm) 
Relative Brachial FMD (%) 
Absolute Femoral FMD (mm) 
Relative Femoral FMD (%) 
73 ± 10 
123 ± 18 


























86 ± 8% HRPEAK 
30 mins 
Body Mass (kg) 
BF (%) 
85.1 ± 19.6 
















Body Mass (kg) 
BF (%) 
Leptin (ng/mL) 
Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
HOMA-IR 
72.1 ± 3.6 
25.5 ± 1.8 
6.9 ± 1.7 
5.73 ± 0.09 
95.1 ± 14.6 
















































Table 8. Ambulation studies included in this review. 
BSWTT body-weight supported treadmill training, HRR heart rate reserve, AUC area under the curve † True study design 
is RCT, presented as pre-post due to two different exercise modalities being tested. *Group x time interaction for RCT and 






n Intervention CMS Outcome Group Baseline  
Intervention (Control) 















Max load without knee buckling 
45 mins 










Body Mass (kg) 
BF (%) 
80.8 ± 14.6 (94.3 ± 
25.0) 

































Max load and speed without knee 




117 ± 20 
























1.36 ± 0.17 
4.67 ± 0.54 
1.46 ± 0.31 
2.61 ± 0.37 
5.12 ± 0.67 
NR 
127 ± 10 
































Minimal load and max speed 
without knee buckling, losing proper 
weight shifting, and upright torso 
Up to 3 x 5-15 min bouts 










Up to 60 mins 
Body Mass (kg) 
BMI (kg/m2) 
BF (%) 
79.7 ± 12.5 
24.5 ± 1.7 


























1.51 ± 0.20 
4.91 ± 0.19 
1.29 ± 0.19 
























Based on self-reported fatigue 
Until self-reported fatigue 
Glucose OGTT (AUC) 

















Up to 3 sets 
Body Mass (kg) 66.0  +1.3 0.06 - 
Table 8
Table 9. Overview of other exercise studies included in review but not grouped for qualitative 
analysis. 
 
†True study design is RCT, presented as pre-post due to two different exercise modalities being tested 





n Intervention CMS Outcome Group Baseline  
Intervention (Control) 
















Up to 180 mins 
Body Mass (kg) 
BMI (kg/m2) 
QUICKI 
89.4 ± 20.3 (75.7 ± 21.0) 
27.1 ± 6.4 (24.8 ± 6.6) 


















ACE: 80-90% V̇O2PEAK, 15 x 
1 mins 
Upper-body RT: 3 x 12 
FES-knee extensions: 40 
reps, increased by ~0.5-1 kg 
every 2 weeks 
Body Mass (kg) 
Fat Mass (kg) 





Fasting Glucose (mmol/L) 
Fasting Insulin (pmol/L) 
Glucose OGTT (AUC) 





87.7 ± 15.0 
- 
- 
1.36 ± 0.66 
4.44 ± 0.99 
1.09 ± 0.16 
2.73 ± 0.80 
6.12 ± 1.14 
115.3 ± 127.1 
- 
- 
4.6 ± 5.1 
3.3 ± 2.0 
1.7 ± 1.0 















































Table 10. Participant characteristics, statistical power, and control group (if applicable) of included studies.  
Study Control Type Statistical 
Power 
N (M/F) Age (y) TSI (y) LOI ASIA 
[32] 
General Exercises NR 33 (29/4) I:33 (15-42), C:37 (19-62) 
I: 1.3 (0.2-12), C: 1.3 
(0.3-10) C7-L3 A-D 
[48] N/A NR 10 (9/1) 39±10 (26-55) 9±9 (1-21) C4-T11 A-C 
[25] 
N/A No 19 (18/1) 
Hybrid: 49±3 (31-64), Hand 
cycle: 47±3 (30-63) 
Hybrid: 21±3 (13-34), 
Hand cycle: 16±2 (9-21) C2-L2 A-D 
[28] N/A NR 10 (8/2) 37±13 (23-55) 12±14 (1-34) C7-T5 A-B 
[62] N/A NR 5 (4/1) 31-50 3-25 C5-T8 A 
[45] N/A NR 16 (16/0) 45±12 12±10 Thoracic A-C 
[39] No exercise intervention NR 14 (14/0) I: 30±3, C: 29±3 I: 19±3, C: 9±3 NR NR 
[42] Instructed to maintain PA levels NR 23 (21/2) I: 39±11, C: 42±13 I: 15±10, C: 9±10 C1-T11 A-D 
[81] N/A NR 8 (6/2) 28±5 (20-34) 10±8 (2-24) C4-C5 B-C 
[80] N/A NR 6 (4/2) 38±15 8±9 C4-T12 A-B 
[53] N/A NR 13 (12/1) 31±5 (21-41) 8±4 (3-16) C4-T10 A-D 
[37] N/A NR 9 (NR) 35±11 (25-50) 12±5 (5-18) C5-T4 NR 
[51] N/A NR 9 (9/0) 39±11 (28-44) 11±10 (1-27) C5-T8 A-C 
[41] N/A NR 34 (26/8) FES: 57±14, RT: 54±17  FES: 9±10, RT: 10±11 C2-T12 C-D 
[83] N/A NR 14 (11/3) 29±8 (20-53) 8±7 (1-24) C4-T12 NR 
[63] Testosterone replacement therapy only Yes 22 (22/0) I: 37±12, C: 35±8 I: 10±9; C: 7±6 C5-T11 A-B (ISNCSCI) 
[31] 
N/A NR 9 (9/0) 
ACE: 41±13 (30-61); FES-
Cycling: 37±7 (29-45) 
ACE: 11±9 (2-26); FES-
Cycling: 7±5 (4-14) C8-T10 A-B 
[64] Standardised diet with no exercise 
intervention NR 9 (9/0) 35±9 (21-47) 13±9 (2-26) C5-T11 A-B 
[79] 
Stretching (3 days/week for 20-25 mins) NR 18 (NR) 
I: 52±12 (28-66), C: 52±15 
(30-72) NR NR C-D 
[54] N/A NR 18 (13/5) 40±2 (25-57) 11±3 C4-T7 NR 
[29] N/A NR 5 (5/0) 40±7 13.9±5.0  C4-L1 A-D 
[78] N/A NR 8 (NR) NR NR NR NR 
[46] 
No exercise intervention NR 34 (NR) 
I: 37±11 (19-65); C: 43±9 
(29-63) 
I: 8±6 (1-22); C: 12±7 (3-
24) C4-S1 A-D 
[56] N/A NR 5 (5/0) 35±3 (28-44) 10±3 (4-23) C5-C7 A-B 
[58] N/A NR 5 (5/0) 35±3 (28-44) 10±3 (4-23) C5-C7 A-B 
[40] N/A NR 11 (6/5) 31±4 (23-36) 12±7 (2-19) C5-T9 NR 
[34] N/A NR 9 (9/0) 38±10 16±7 T8-L1 A-B 
[77] N/A NR 6 (6/0) 46±5 (24-56)  NR T4-T10 A-B 
[50] N/A NR 7 (5/2) 45±8 (30-53)  20±14 (3-40) C5-T10 NR 
[88] No exercise intervention Yes 48 (30/11) I: 42±13; C: 34±12 I: 7±10; C: 6±7  NR C-D 
[57] 




[84] N/A NR 5 (4/1) 60±6 8±5 C7-T10 NR 
[33] No exercise intervention NR 15 (9/6) 33±6 (22-46) 7±4 (2-16) C5-T11 A-B 
[44] Standard Care NR 17 (11/6) 37±7 (23-53) 10±7 (2-27) C4-L1 A-C 
[73] N/A NR 12 (10/2) 36±12 (16-45) 11±6 (5-24) C6-L1 A-C 
[87] N/A NR 16 (13/3) 28±7 (21-45) 4±3 (0.7-9)  T4-T11 NR 
[59] N/A NR 8 (8/0) 39±3 >4 C5-T11 A-B 
[52] N/A NR 18 (16/2) 40±11 (26-61) 3±2 (1-9) C3-L1 B-D 
[89] N/A NR 6 (6/0) 50±8 (36-58) 24±8 (10-30) C6-T6 A-B 
[70] N/A NR 5 (5/0) 36±5 13±7 C5-T10 A 
[30] 
N/A NR 14 (NR) 
Supine: 34±12; Sitting: 
33±7  
Supine: 9±13; Sitting: 
14±6 CT-T1 NR 
[35] 
N/A NR 
12 (11/1) (2 non-
SCI) 38±10 (22-58) 15±7 (4-29) C6-L3 NR 
[43] No exercise intervention NR 20 (20/0) I: 25±3; C: 26±3 I: 10±4; C: 9±4 T9-T12 A 
[60] N/A NR 10 (8/2) 35 (27-45) 12 (3-23) C6 and T4 NR 
[36] N/A NR 12 (12/0) 31±9 (19-45) 2±1 (1-3) <T10 NR 
[47] N/A NR 5 (5/0) 38±4 (34-43) 5±1 (1-7) T6-T12 NR 
[26] No exercise intervention Yes 21 (15/6) I: 46±6, C: 48±10 I: 20±10; C: 14±11 T4-L3 A-D 
[71] N/A NR 4 (4/0) 20-35 4±3 (1-8) T4-T6 NR 
[86] N/A NR 9 (8/1) 31±3 8±3 C4-T12 C 
[69] N/A NR 11 (7/4) 29±15 (18-54) 6±3 (0.5-11)  C4-T6 NR 
[68] N/A NR 19 (16/3) 19-47 2-17 C4-T10 NR 
[55] N/A NR 8 (7/1) 32±2 (23-41) 12±2 (5-24) C7-L1 NR 
[65] N/A No 12 (9/3) 38±13 (19-63) 6±6 (1-17) C4-T10 NR 
[27] No exercise intervention NR 17 (17/0) 30±4 (I & C) 5±0 ≤T5 NR 
[66] N/A No 14 (11/3) 27±5 (28-57) 8±7 (2-22) C4-T7 A-B 
[49] Standard Care NR 45 (38/7) I: 37±12; C: 35±12  I: 8 (1.5-43), C: 6 (1-27) C1-L5 A-C 
[74] N/A Yes 12 (11/1) 33±4 (22-60) 8±3 (0-33) C4-T2 NR 
[61] No exercise intervention NR 15 (15/0) 33 (21-48) 9 (1-21) NR A-B 
[85] N/A NR 9 (8/1) 31±3 8±3 C4-T12 C 
[67] N/A NR 5 (5/0) 36±5 13±7 C5-T10 A 
[72] N/A NR 9 (8/1) 39±3 (25-52) 11±3 (1-25) C5-T12 A, C 
[75] N/A NR 10 (9/1) 39±9 (23-53) 11±6 (1-20) T1-T12 A, C 
[82] 
N/A NR 14 (10/4) 51±17 2-10 NR 
Motor 
Incomplete 
[76] N/A NR 10 (8/2) 47±18 18±14 (2-39) T4-T12 A-C 
[38] N/A NR 11 (11/0) 31±8 (20-49) 2±1 (0.5-4)  T8-T12 A 
TSI time since injury, LOI level of injury, ASIA American Spinal Injury Association Impairment Scale, NR not reported, ISNCSCI International Standards for Neurological Classification of 
Spinal Cord Injury, ROM range of motion; I Intervention, C Control. 
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Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Title Page 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
1-2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3-4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
4 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
4 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
5 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
5-6 




Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
6 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
6-7 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
5-6 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
6 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  6 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
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Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
N/A 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions 
at each stage, ideally with a flow diagram.  
Figure 1 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
Tables 3-10 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Tables 3-10 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Tables 3-10 
Synthesis of results  21 Present the main results of the review. If meta-analyses are done, include for each, confidence intervals and 
measures of consistency. 
Table 2 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  N/A 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  N/A 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance 
to key groups (e.g., healthcare providers, users, and policy makers).  
9-14 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
13 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  13-14 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 
the systematic review.  
N/A 
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